Inflammatory markers and stroke

被引：35

作者：

Elkind M.S.V. ^{[1
]}

机构：

[1] Department of Neurology, Columbia University, New York-Presbyterian Hospital, New York, NY 10032

来源：

Current Cardiology Reports | 2009年 / 11卷 / 1期

关键词：

Ischemic Stroke; Stroke Patient; Stroke Risk; Carotid Plaque; Cardiovascular Health Study;

D O I：

10.1007/s11886-009-0003-2

中图分类号：

学科分类号：

摘要：

Basic and animal research implicate inflammatory mechanisms in the pathogenesis and progression of atherosclerosis, plaque rupture, thrombosis, and stroke. Inflammatory biomarkers, particularly high-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2, have been identified as potential predictors of stroke risk and prognosis. Infections may also precipitate stroke. Medications, especially hydroxymethylglutaryl coenzyme A reductase inhibitors (statins), reduce inflammatory marker levels independently of lipid effects, and the ability of statins to reduce coronary events and stroke correlates with their effect on inflammatory biomarkers. Vaccination against influenza may also reduce stroke risk. Determining whether reduction of biomarkers reduces risk of recurrent stroke, however, requires further study before inflammatory markers become a routine part of the evaluation of stroke patients. © 2009 by Current Medicine Group LLC.

引用

页码：12 / 20

页数：8

共 52 条

[11]

Curb J.D., Abbott R.D., Rodriguez B.L., Sakkinen P., Popper J.S., Yano K., Tracy R.P., C-reactive protein and the future risk of thromboembolic stroke in healthy men, Circulation, 107, 15, pp. 2016-2020, (2003)

[12]

Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H.M., Polak J.F., Sutton-Tyrrell K., Herrington D.M., Price T.R., Cushman M., C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly the cardiovascular health study, Circulation, 108, 2, pp. 166-170, (2003)

[13]

Verma S., Szmitko P.E., Yeh E.T.H., C-Reactive Protein: Structure Affects Function, Circulation, 109, 16, pp. 1914-1917, (2004)

[14]

Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., Vinicor F., Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association, Circulation, 107, 3, pp. 499-511, (2003)

[15]

Ridker P.M., Buring J.E., Rifai N., Cook N.R., Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score, JAMA, 297, pp. 611-619, (2007)

[16]

Woodward M., Lowe G.D.O., Campbell D.J., Colman S., Rumley A., Chalmers J., Neal B.C., Patel A., Jenkins A.J., Kemp B.E., MacMahon S.W., Associations of inflammatory and hemostatic variables with the risk of recurrent stroke, Stroke, 36, 10, pp. 2143-2147, (2005)

[17]

Welsh P., Lowe G.D., Chalmers J., Et al., Associations of proinflammatory cytokines with the risk of recurrent stroke, Stroke, 39, pp. 2226-2230, (2008)

[18]

Arenillas J.F., Alvarez-Sabin J., Molina C.A., Et al., Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis, Stroke, 39, pp. 1456-1463, (2008)

[19]

Montaner J., Fernandez-Cadenas I., Molina C.A., Ribo M., Huertas R., Rosell A., Penalba A., Ortega L., Chacon P., Alvarez-Sabin J., Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis, Stroke, 37, 5, pp. 1205-1210, (2006)

[20]

Cho A.-H., Kim J.S., Jeon S.-B., Kwon S.U., Lee D.H., Kang D.-W., Mechanism of multiple infarcts in multiple cerebral circulations on diffusion-weighted imaging, Journal of Neurology, 254, 7, pp. 924-930, (2007)

← 1 2 3 4 5 6 →